APY Therapeutics is developing arylmyxopyronins–APYs–as novel first-in-class oral treatments for lower-respiratory-tract infections and skin-and-soft-tissue bacterial infections.
APY Therapeutics is a member of INCATE (INCubator for Antibacterial
Therapies in Europe).
Company Details
- Employees
- 1
- Founded
- 2025
- Address
- North Brunswick, Nj 08902, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://apytherapeutics.com/
- Keywords
- Ixelles.
- HQ
- North Brunswick, NJ
Apy Therapeutics, Llc Questions
Apy Therapeutics, Llc's website is https://apytherapeutics.com/
Apy Therapeutics, Llc's LinkedIn profile is https://www.linkedin.com/company/apy-therapeutics-llc
Apy Therapeutics, Llc has
1 employees.
View email and phone details for 1
employees at Apy Therapeutics, Llc.
Apy Therapeutics, Llc's industry is
Biotechnology Research
Apy Therapeutics, Llc's top competitors are
Incate,
Lunar Biosciences,
Sciensano,
Baxiva,
Adina Technologies,
Moderna,
Alpioner Therapeutics.
Apy Therapeutics, Llc's categories are Biotechnology Research
Apy Therapeutics, Llc's founding year is 2025
